Invention Grant
- Patent Title: Inhibitors of immune checkpoint modulators and related methods
-
Application No.: US15130538Application Date: 2016-04-15
-
Publication No.: US10702526B2Publication Date: 2020-07-07
- Inventor: Kevin R. Webster , Vikas Goel
- Applicant: eFFECTOR Therapeutics, Inc.
- Applicant Address: US CA San Diego
- Assignee: eFFECTOR Therapeutics Inc.
- Current Assignee: eFFECTOR Therapeutics Inc.
- Current Assignee Address: US CA San Diego
- Agency: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61K31/52 ; A61K31/506 ; A61K39/395 ; A61K31/713 ; A61K45/06 ; A61K39/00
Abstract:
The present disclosure relates to the use MNK-specific inhibitors to inhibit immunosuppression components, such as immune checkpoint proteins PD-1, PD-L1, LAG3, and/or immunosuppressive cytokines, such as IL-10, in order to inhibit or release immune suppression in certain diseases, such as cancer and infectious disease.
Public/Granted literature
- US20160303124A1 INHIBITORS OF IMMUNE CHECKPOINT MODULATORS AND RELATED METHODS Public/Granted day:2016-10-20
Information query
IPC分类:
